Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

Pray, it's very simple...for my current investment strategy with Mast everything hinges on the Phase 3 EPIC trial. Even with many other indications in the pipeline, it's all about that top line data release first and foremost. If they bring that home successfully and the market reacts like I believe they will, I will make alot of money. After that critical event for Mast, I will 're-evaluate my position looking at their commercialization of vepoloxamer in SCD and where things stand with their other indications in Ali, Heart Failure, Stroke and PAH with AIR001. It's not that difficult to figure out for me.